Physician profile
Edward B Strauss
NPI 1982678421
$764.50
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $159.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $114.25 | 2019-2020 | |
| Lilly USA, LLC | $108.56 | 2019-2020 | |
| Amgen INC. | $78.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $76.39 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $60.44 | 2020 | |
| Abbvie INC. | $44.08 | 2019 | |
| Celgene Corporation | $40.40 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.16 | 2019 | |
| Janssen Biotech, INC. | $33.86 | 2020 | |
| Merck Sharp & Dohme LLC | $30.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.09 | 2019 | |
| Tesaro, INC. | $25.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.29 | 2019 | |
| Ge Healthcare | $19.84 | 2019 | |
| Angiodynamics, INC. | $19.19 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bracco Diagnostics INC. | $16.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Strauss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.